B-66/100

Is Arcosa Inc (ACA) a risky stock?

Sector: Construction Price: $145.11 Composite: 66/100

As of July 24, 2026, Clavix grades Arcosa Inc (ACA) B- for risk, a composite score of 66 out of 100 on an A+ to F scale, which puts ACA in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 24, 2026. Clavix regrades every trading day.

The five risk dimensions behind ACA's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ACA scores on each, as of July 24, 2026.

Financial healthbalance sheet, margins, cash flow
61
News sentimentscored, sourced recent coverage
49
Macro exposuresensitivity to rates, dollar, oil
64
Sector resiliencestrength vs the broad market
72
Price stabilitydrawdown and volatility
52

What's moving ACA's risk right now

Company-specific signals Clavix flags behind ACA's current grade, drawn from recent news and filings as of July 24, 2026.

Valuation · raising risk

Texas Capital lowered its rating on Arcosa, pointing to a more cautious near-term outlook. Other firms like Barclays still carry higher price targets, leaving the overall rating picture mixed.

Regulatory · raising risk

Ademi LLP is probing whether Arcosa is securing a fair price for public shareholders in the CRH acquisition. The investigation could pressure the company to improve terms or delay closing.

Execution · supporting the grade

CRH announced a deal to acquire Arcosa for $8.5 billion, its largest acquisition to date. The move expands CRH's North American infrastructure and aggregates footprint, though it will add debt and integration risk.

Recent ACA news

The latest headlines Clavix ingested for Arcosa Inc, newest first. These feed the news-sentiment dimension of ACA's grade.

What a B- grade means

On the Clavix A+ to F scale, ACA's composite of 66 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ACA or any security. Grades are risk indicators, not predictions of return. Data may be delayed.